Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
​Treating cancer like a rare disease
Brad Smith, PhD
Jun 01, 2017
  • Blogs
  • Treating cancer like a rare disease

With the advent of targeted kinase inhibitors and the use of genomics to target specific, and often rare, patient populations, oncology is rapidly transitioning from a number of broad indications, to a therapeutic area composed of dozens of rare diseases. Each new treatment and test targets an ever smaller subset of the cancer patient population, forcing oncology researchers to rethink their approach to recruiting patients into clinical trials.

One place to find answers to these challenges is from rare disease researchers, who are implementing effective methods to succeed in focusing on patients rather than screening. There are a number of similarities between the emerging oncology treatment paradigm and rare disease research. Both areas must leverage a deep knowledge of disease molecular biology matched with drug mechanisms of action. Both hope to provide long term improvements in patient outcomes by correcting the defects underlying disease. Rare disease researchers are leveraging innovative approaches such as connecting directly with patient communities, supporting registries to better understand patient and disease natural histories and customized recruiting strategies to accommodate the unique needs of these small and dispersed populations. Approaches that will enable oncology clinical researchers include:

  • Build a patient registry. Rare disease researchers often registries to gather data about the patient’s history with the disease, the current standard of care and to identify patients and treating physicians when they begin recruiting. Once the treatment is developed, the data collected in these registries can help demonstrate effectiveness to regulators and payers as part of the approval process, all of which is especially beneficial for precision oncology research. For the patients and investigators, registries may provide access to novel tests and information about their condition.
  • Support Direct-to-Patient activities including online communities. When patients are diagnosed with a disease, they often turn to online support groups for information, advice, and connection with other patients and care givers. These groups can be particularly important for sufferers of rare diseases – including targeted cancers – where patients may feel isolated. However they are often poorly funded and depend on dedicated leaders of patient advocacy groups because the population of patients is so small. Developers of targeted oncology drugs can benefit from sponsoring these sites, providing resources, education, and information about current research in various direct-to-patient approaches. In this way they establish themselves as an ally to the patient community and they have a place to share updates and trial information with the patients and physicians they want to recruit. These efforts may have very tangible benefits for patient retention and compliance and new options for patient reported outcomes.
  • Use real-world data to build sites around patients. When dealing with dispersed patient populations, developers can’t expect to simply open trial sites and hope the patients will come. Instead, they should begin by first identifying patient pools and medical centers where targeted patients are likely to seek treatment and establish trial sites near them. This information can be gathered by evaluating electronic medical records, insurance claims, diagnostic data, and patient registries to make evidence-based decisions about where patients are located. By bringing the trial to patients, the research team makes it physically convenient for patients while enabling them to be treated by their own physicians.
  • Speed trial and site ramp up. When patients are dealing with a rare disease or a cancer diagnosis, they don’t have time to waste waiting for a trial to begin. The timing of a trial launch and site availability may mean that a patient can’t participate. One way we are tackling this challenge, is by establishing a pre-approved network of investigative sites across the U.S. that are pre-screened and ready to participate in any oncology trial for which they have access to patients. In this model, a site is only opened after the first patient is identified, which eliminates the risk of investing in sites that won’t ever find recruits, while opening the trial to patients across the nation. Most often, these networks are disease focused, similar to what rare disease patient advocacy groups have done with investigator consortia.

While there are no silver bullets for recruiting patients to targeted oncology trials, the lessons learned in the rare disease research space can speed the process of finding and recruiting patients and eliminate much of the waste that comes with opening dozens of trial sites that never recruit a single patient. More broadly, these lessons can help move oncology clinical research and practice to be more patient centric, better suited to long-term care of chronic disease.

Related solutions

Rare Diseases

Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.

Therapeutic & Specialty Expertise

Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.

Contact Us